{"SLR NAME":"Host genetic variants associated with COVID-19 prognosis and susceptibility: a systematic review and meta-analysis","References":[{"title1":"Association of tumor necrosis factor alpha ?308 single nucleotide polymorphism with SARS CoV?2 infection in an Iraqi Kurdish population","References":[{"title2":"COVID-19: immunology, immunopathogenesis and potential therapies","References":[{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China"},{"title3":"Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment"},{"title3":"Coronavirus infections and immune responses"},{"title3":"A human monoclonal antibody blocking SARS-CoV-2 infection"},{"title3":"The proximal origin of SARS-CoV-2"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): a review"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Structural basis of receptor recognition by SARS-CoV-2"},{"title3":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment"},{"title3":"The epidemiology and pathogenesis of Coronavirus Disease (COVID-19) outbreak"},{"title3":"The incubation period of Coronavirus Disease 2019 (COVID-19) From publicly reported confirmed cases: estimation and application"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Anosmia and ageusia: common findings in COVID-19 patients"},{"title3":"Acute respiratory distress syndrome"},{"title3":"Brazilian diabetes society study G. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis"},{"title3":"Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020"},{"title3":"Gender differences in patients with COVID-19: focus on severity and mortality"},{"title3":"Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity"},{"title3":"Is the kidney a target of SARS-CoV-2?"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Cardiovascular disease and COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"COVID-19 and multiorgan response"},{"title3":"Angiotensin-converting enzyme 2 in lung diseases"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor"},{"title3":"Structure analysis of the receptor binding of 2019-nCoV"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"},{"title3":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome"},{"title3":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients"},{"title3":"Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series"},{"title3":"Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression"},{"title3":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy"},{"title3":"SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines"},{"title3":"Sodium chromo-glycate and palmitoylethanolamide: a possible strategy to treat mast cell-induced lung inflammation in COVID-19"},{"title3":"COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin"},{"title3":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients"},{"title3":"COVID-19: immunology and treatment options"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19"},{"title3":"Longitudinal analyses reveal immunological misfiring in severe COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Detection of pyroptosis by measuring released lactate dehydrogenase activity"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer"},{"title3":"Complement as a target in COVID-19?"},{"title3":"Complement activation in patients with COVID-19: a novel therapeutic target"},{"title3":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients"},{"title3":"Neurologic features in severe SARS-CoV-2 infection"},{"title3":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases"},{"title3":"TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection"},{"title3":"The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing"},{"title3":"Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing"},{"title3":"A dynamic immune response shapes COVID-19 progression"},{"title3":"COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis"},{"title3":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure"},{"title3":"Immunotherapeutic implications of IL-6 blockade for cytokine storm"},{"title3":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome"},{"title3":"Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19"},{"title3":"Efficacy of tocilizumab in patients hospitalized with COVID-19"},{"title3":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19"},{"title3":"Reinfection could not occur in SARS-CoV-2 infected rhesus macaques"},{"title3":"Viruses, dendritic cells and the lung"},{"title3":"Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells"},{"title3":"The powerful immune system against powerful COVID-19: a hypothesis"},{"title3":"Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells"},{"title3":"Role of dendritic cells in SARS coronavirus infection"},{"title3":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans"},{"title3":"Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"Receptor-dependent coronavirus infection of dendritic cells"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity"},{"title3":"Elucidating the mechanisms of influenza virus recognition by Ncr1"},{"title3":"NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection"},{"title3":"Viral infection of human natural killer cells"},{"title3":"Natural killer cell immunotypes related to COVID-19 disease severity"},{"title3":"Influenza virus directly infects human natural killer cells and induces cell apoptosis"},{"title3":"A molecular cell atlas of the human lung from single cell RNA sequencing"},{"title3":"Neutrophil: a cell with many roles in inflammation or several cell types?"},{"title3":"Neutrophil extracellular traps in immunity and disease"},{"title3":"Neutrophil extracellular traps in arterial and venous thrombosis"},{"title3":"Clinical characteristics of 82 cases of death from COVID-19"},{"title3":"Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan"},{"title3":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications"},{"title3":"Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology"},{"title3":"Basophils and allergic inflammation"},{"title3":"State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?"},{"title3":"Virus enhances histamine release from human basophils"},{"title3":"Human blood-circulating basophils capture HIV-1 and Mediate Viral trans-infection of CD4+ T cells"},{"title3":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China"},{"title3":"Eosinophil responses during COVID-19 infections and coronavirus vaccination"},{"title3":"Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19"},{"title3":"Dynamic changes in routine blood parameters of a severe COVID-19 case"},{"title3":"Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China"},{"title3":"COVID-19 and asthma: reflection during the pandemic"},{"title3":"Mast cell: a multi-functional master cell"},{"title3":"Mast cell-induced lung injury in mice infected with H5N1 influenza virus"},{"title3":"Mast cell responses to viruses and pathogen products"},{"title3":"Mast cell stabilization improves survival by preventing apoptosis in sepsis"},{"title3":"Repositioning chromones for early anti-inflammatory treatment of COVID-19"},{"title3":"Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction"},{"title3":"Angiotensin II generation by mast cell alpha- and beta-chymases"},{"title3":"Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19)"},{"title3":"The molecular biology of SARS coronavirus"},{"title3":"CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome"},{"title3":"Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans"},{"title3":"Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection"},{"title3":"Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection"},{"title3":"Coronavirus protective immunity is short-lasting"},{"title3":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients"},{"title3":"High levels of circulating GM-CSF + CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study"},{"title3":"Clinical and immunological features of severe and moderate Coronavirus Disease 2019"},{"title3":"nEn -T cells: an Unpolished sword in human anti-infection immunity"},{"title3":"Aberrant pathogenic GM-CSF + T cells and inflammatory CD14 + CD16+. Monocytes in severe pulmonary syndrome patients of a new coronavirus"},{"title3":"Multidimensional assessment of alveolar T cells in critically ill patients"},{"title3":"Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2"},{"title3":"Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19"},{"title3":"Functional alteration of innate T cells in critically ill COVID-19 patients"},{"title3":"Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Immunological memory to SARS-CoV-2 assessed for greater than six months after infection"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"ular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020"},{"title3":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study"},{"title3":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals"},{"title3":"Disappearance of antibodies to SARS-associated coronavirus after recovery"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"},{"title3":"Persistence of antibodies against middle east respiratory syndrome coronavirus"},{"title3":"Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with High Attack Rate"},{"title3":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months"},{"title3":"Fc receptors in antibody-dependent enhancement of viral infections"},{"title3":"The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement"},{"title3":"Role of aging and the immune response to respiratory viral infections: potential implications for COVID-19"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes"},{"title3":"Understanding the age divide in COVID-19: why are children overwhelmingly spared?"},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 Coronavirus Disease in China"},{"title3":"Household secondary attack rate of COVID-19 and associated determinants"},{"title3":"Pediatric SARS-CoV-2: clinical presentation, infectivity, and immune responses"},{"title3":"Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019"},{"title3":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)"},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19"},{"title3":"Hydroxychloroquine: from malaria to autoimmunity"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"},{"title3":"Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines"},{"title3":"The convalescent sera option for containing COVID-19"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection"},{"title3":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience"},{"title3":"Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection"},{"title3":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma"},{"title3":"COVID-19: FDA approves use of convalescent plasma to treat critically ill patients"},{"title3":"Corticosteroids: mechanisms of action in health and disease"},{"title3":"A general introduction to glucocorticoid biology"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated cochrane systematic review and meta-analysis"},{"title3":"Corticosteroid treatment of patients with Coronavirus Disease 2019 (COVID-19)"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Coronavirus breakthrough: dexamethasone is first drug shown to save lives"},{"title3":"Molecular docking analysis of amyloid precursor protein with compounds from the Australian cowplant"},{"title3":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly"},{"title3":"COVID-19 as an acute inflammatory disease"},{"title3":"Naproxen exhibits broad anti-influenza virus activity in mice by impeding viral nucleoprotein nuclear export"},{"title3":"Response to the emerging novel coronavirus outbreak"},{"title3":"Indomethacin has a potent antiviral activity against SARS coronavirus"},{"title3":"Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19"},{"title3":"IVIG-mediated effector functions in autoimmune and inflammatory diseases"},{"title3":"Clinical uses of intravenous immunoglobulin"},{"title3":"Advances in the understanding of the mechanism of action of IVIg"},{"title3":"Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: a case series"},{"title3":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19"},{"title3":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic"},{"title3":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine"},{"title3":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology"},{"title3":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody"},{"title3":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2"},{"title3":"Potent neutralizing monoclonal antibodies directed to multiple epitopes on the SARS-CoV-2 spike"},{"title3":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques"},{"title3":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies"},{"title3":"Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining"},{"title3":"COVID-19 pandemic: a pragmatic plan for Ayurveda Intervention"},{"title3":"Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective"},{"title3":"An overview on adverse drug reactions to traditional Chinese medicines"},{"title3":"Role of herbal medicine in boosting immune system"},{"title3":"A review on herbal plants as immunomodulators"},{"title3":"Immunity-boosting spices and the novel coronavirus"},{"title3":"Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay"},{"title3":"Remdesivir for the treatment of COVID-19 - preliminary report"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors"},{"title3":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur"},{"title3":"The gut microbiota-masters of host development and physiology"},{"title3":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases"},{"title3":"Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota"},{"title3":"Interactions between commensal intestinal bacteria and the immune system"},{"title3":"An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system"},{"title3":"Diversity of the human intestinal microbial flora"},{"title3":"The human microbiota in health and disease"},{"title3":"Probiotics"},{"title3":"Gut microbiota in cardiovascular health and disease"},{"title3":"Genetic aspects of intestinal permeability in inflammatory bowel disease"},{"title3":"Increased tight junctional permeability is associated with the development of colon cancer"},{"title3":"Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs"},{"title3":"Alterations in gut microbiota of patients with COVID-19 during time of hospitalization"},{"title3":"Gut microbiota and COVID-19- possible link and implications"},{"title3":"Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 infectivity"},{"title3":"Use of probiotics in gastrointestinal disorders: what to recommend?"},{"title3":"Molecular aspects of intestinal calcium absorption"},{"title3":"Bacillus clausii inhibits bone loss by skewing Treg-Th17 cell equilibrium in postmenopausal osteoporotic mice model"},{"title3":"Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance"},{"title3":"The pros, cons, and many unknowns of probiotics"},{"title3":"Probiotics and COVID-19: one size does not fit all"},{"title3":"Anti-inflammatory effect of multistrain probiotic formulation (L. rhamnosus, B. lactis, and B. longum"},{"title3":"Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition"},{"title3":"Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain"},{"title3":"Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism"},{"title3":"Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases"},{"title3":"Probiotics in autoimmune and inflammatory disorders"}]},{"title2":"The role of immunogenetics in COVID-19","References":[{"title3":"New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention"},{"title3":"Characteristics of SARS-CoV-2 and COVID-19"},{"title3":"The cytokine storm and COVID-19"},{"title3":"Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19)"},{"title3":"Molecular mechanisms of severe acute respiratory syndrome (SARS)"},{"title3":"Treatment and vaccines for severe acute respiratory syndrome"},{"title3":"The Immune Response and Immunopathology of COVID-19"},{"title3":"Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes"},{"title3":"Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India"},{"title3":"Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility"},{"title3":"The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences"},{"title3":"Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19"},{"title3":"CoViD-19 Susceptibility"},{"title3":"Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity"},{"title3":"Longitudinal analyses reveal immunological misfiring in severe COVID-19"},{"title3":"Cytokine Storm"},{"title3":"Immunogenetics of viral infections"},{"title3":"Immunogenetic Association Underlying Severe COVID-19"},{"title3":"Possible role of ABO system in age-related diseases and longevity: A narrative review"},{"title3":"Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily"},{"title3":"Relationship between the ABO Blood Group and the COVID-19 Susceptibility"},{"title3":"Genetic Risk of Severe Covid-19"},{"title3":"Associations between blood type and COVID-19 infection, intubation, and death"},{"title3":"Association between ABO Blood Group System and COVID-19 Susceptibility in Wuhan"},{"title3":"Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients"},{"title3":"Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis"},{"title3":"Reduced prevalence of SARS-CoV-2 infection in ABO blood group O"},{"title3":"Genomewide Association Study of Severe Covid-19 with Respiratory Failure"},{"title3":"HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity"},{"title3":"Blood type and outcomes in patients with COVID-19"},{"title3":"Lack of association between SNPsrs8176719(O blood group) and COVID-19: Data from Spanish age matched patients and controls"},{"title3":"Innate immunity and inflammation in ageing: A key for understanding age-related diseases"},{"title3":"SARS CoV2 infection _The longevity study perspectives"},{"title3":"Blood Groups in Infection and Host Susceptibility"},{"title3":"Beyond immunohaematology: The role of the ABO blood group in human diseases"},{"title3":"Regulation of major histocompatibility complex class II gene expression, genetic variation and disease"},{"title3":"DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas"},{"title3":"Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines"},{"title3":"HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy"},{"title3":"HLA genetic polymorphisms and prognosis of patients with COVID-19"},{"title3":"HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients"},{"title3":"The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2"},{"title3":"Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review"},{"title3":"Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection"},{"title3":"Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)"},{"title3":"Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients"},{"title3":"A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients"},{"title3":"The Effect of HLA-B27 on Susceptibility and Severity of COVID-19"},{"title3":"Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2"},{"title3":"Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)"},{"title3":"Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis"},{"title3":"Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients"},{"title3":"A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach"},{"title3":"Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19"},{"title3":"Autoimmune diseases and 8.1 ancestral haplotype: An update"},{"title3":"Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype"},{"title3":"Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data"},{"title3":"Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: Relevance for epitope specific vaccination protocols"},{"title3":"Genetic variation in human leukocyte antigen and susceptibility to acute myeloid leukemia"},{"title3":"Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases"},{"title3":"Dimorphism of HLA-E and its Disease Association"},{"title3":"Dysregulated Interferon Response Underlying Severe COVID-19"},{"title3":"The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19"},{"title3":"Aging in COVID-19: Vulnerability, immunity and intervention"},{"title3":"Age- severity matched cytokine profiling reveals specific signatures in Covid-19 patients"},{"title3":"Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?"},{"title3":"Immunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People"},{"title3":"Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity"},{"title3":"Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention"},{"title3":"Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome"},{"title3":"COVID-19: Age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study"},{"title3":"Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection"},{"title3":"Natural killer cell immunotypes related to COVID-19 disease severity"},{"title3":"The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis"},{"title3":"Immunocytometric analysis of COVID patients: A contribution to personalized therapy?"},{"title3":"Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain"},{"title3":"Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease"},{"title3":"Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study"},{"title3":"Association of Peripheral Lymphocyte and the Subset Levels With the Progression and Mortality of COVID-19: A Systematic Review and Meta-Analysis"},{"title3":"Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19"},{"title3":"The characteristics and predictive role of lymphocyte subsets in COVID-19 patients"},{"title3":"Major reduction of NKT cells in patients with severe COVID-19 pneumonia"},{"title3":"Immunogenetics of ageing"},{"title3":"The role of DNA methylation and hydroxymethylation in immunosenescence"},{"title3":"Epigenomic drivers of immune dysfunction in aging"},{"title3":"Immunosenescence and immunogenetics of human longevity"},{"title3":"The epigenetic implication in coronavirus infection and therapy"},{"title3":"Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19"},{"title3":"Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages"},{"title3":"Cytokine-targeted therapy in severely ill COVID-19 patients: Options and cautions"},{"title3":"Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19"},{"title3":"The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?"},{"title3":"Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia"},{"title3":"Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study"},{"title3":"Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study"},{"title3":"Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19"},{"title3":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19:Preliminary report"},{"title3":"Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology"},{"title3":"Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways"},{"title3":"Detection of Viral Infections by Innate Immunity"},{"title3":"Host genetic susceptibility to viral infections: The role of type I interferon induction"},{"title3":"Trafficking of endosomal Toll-like receptors"},{"title3":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19"},{"title3":"The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review"},{"title3":"Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): Rapid systematic review and field synopsis"},{"title3":"Genetic mechanisms of critical illness in Covid-19"},{"title3":"Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019"},{"title3":"The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19"},{"title3":"Clinical and molecular characterization of COVID-19 hospitalized patients"},{"title3":"Association of TNF-alpha G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients"},{"title3":"APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort"},{"title3":"ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank"},{"title3":"RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase"},{"title3":"IFITM3: How genetics influence influenza infection demographically"},{"title3":"IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells"},{"title3":"Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection"},{"title3":"Breadth of concomitant immune responses prior to patient recovery: A case report of non-severe COVID-19"},{"title3":"PACT, a protein activator of the interferon-induced protein kinase, PKR"},{"title3":"Association of tumor necrosis factor-alpha and -beta gene polymorphisms in inflammatory bowel disease"},{"title3":"The effects of tumor necrosis factor-alpha (TNF-alpha) rs1800629 and rs361525 polymorphisms on sepsis risk"},{"title3":"Association between Tumor Necrosis Factor-308 G/A Polymorphism and Chronic Obstructive Pulmonary Disease Risk in Chinese Population: Evidence from a Meta-Analysis"},{"title3":"Promoter Polymorphism (-308G/A) of Tumor Necrosis Factor-Alpha (TNF-alpha) Gene and Asthma Risk: An Updated Meta-Analysis"},{"title3":"Association of single nucleotide polymorphisms in TNF-alpha (-308G/A and -238G/A) to dengue: Case-control and meta-analysis study"},{"title3":"Association of TNF-alpha rs1800629, CASP3 rs72689236 and FCGR2A rs1801274 Polymorphisms with Susceptibility to Kawasaki Disease: A Comprehensive Meta-Analysis"},{"title3":"Association of-308G/A Polymorphism and Serum Level of TNF-alpha with Bronchial asthma in Children"},{"title3":"Impact of gene polymorphism of TNF-alpha rs 1800629 and TNF-beta rs 909253 on plasma levels of South Indian breast cancer patients"},{"title3":"Association between TNF-alpha-308G&gt;A and -238G&gt;A gene polymorphisms and TNF-alpha serum levels in Mexican colorectal cancer patients"},{"title3":"The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease"},{"title3":"Effect of TNF-alpha -308G/A (rs1800629) Promoter Polymorphism on the Serum Level of TNF-alpha Among Iraqi Patients with Generalized Vitiligo"},{"title3":"The Regulatory Function of CCR9+ Dendritic Cells in Inflammation and Autoimmunity"},{"title3":"Interfering with leukocyte trafficking in Crohn's disease"},{"title3":"CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways"},{"title3":"XCL1 and XCR1 in the immune system"},{"title3":"Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1"},{"title3":"Correlations of IL-6, IL-6R, IL-10 and IL-17 gene polymorphisms with the prevalence of COVID-2019 infection and its mortality rate"},{"title3":"Study of association of the rs2275913 IL-17A single nucleotide polymorphism and susceptibility to cutaneous leishmaniasis caused by Leishmania braziliensis"},{"title3":"The IL-17A rs2275913 single nucleotide polymorphism is associated with protection to tuberculosis but related to higher disease severity in Argentina"},{"title3":"Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: An updated meta-analysis"},{"title3":"Correlations of IL-17 and NF-kappaB gene polymorphisms with susceptibility and prognosis in acute respiratory distress syndrome in a chinese population"},{"title3":"Association of interleukin-17a rs2275913 gene polymorphism and asthma risk: A meta-analysis"},{"title3":"IL-17A gene polymorphism rs2275913 is associated with the development of asthma after bronchiolitis in infancy"},{"title3":"Single-Nucleotide Polymorphisms of IL-17 Gene Are Associated with Asthma Susceptibility in an Asian Population"},{"title3":"Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data"},{"title3":"WSB1: From homeostasis to hypoxia"},{"title3":"WSB-1, a novel IL-21 receptor binding molecule, enhances the maturation of IL-21 receptor"},{"title3":"Regulation of the germinal center and humoral immunity by interleukin-21"},{"title3":"IL-21 in Homeostasis of Resident Memory and Exhausted CD8 T Cells during Persistent Infection"},{"title3":"The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis"},{"title3":"Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence"},{"title3":"Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses"},{"title3":"Genome-wide association study of antibody response to smallpox vaccine"},{"title3":"Regulation of Macrophage Polarization by RON Receptor Tyrosine Kinase Signaling"},{"title3":"The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity"},{"title3":"Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide"},{"title3":"Macrophage-stimulating protein and RON receptor tyrosine kinase: Potential regulators of macrophage inflammatory activities"},{"title3":"LAPTMs regulate lisosomal function and interact with mucolipin 1: New clues for understanding mucolipidosis type IV"},{"title3":"LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation"},{"title3":"Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS"},{"title3":"Substance use and substance use disorder, in relation to COVID-19: Protocol for a scoping review"},{"title3":"Impact of COVID-19 on Resettled Refugees"},{"title3":"The SARS-CoV-2 pandemic: A syndemic perspective"},{"title3":"Health disparities: Intracellular consequences of social determinants of health"},{"title3":"The impact of outdoor air pollution on COVID-19: A review of evidence from in vitro, animal, and human studies"},{"title3":"The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2"},{"title3":"Environmental pollutants and the immune response"},{"title3":"Drinking water pollutants may affect the immune system: Concerns regarding COVID-19 health effects"},{"title3":"Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?"},{"title3":"Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization"},{"title3":"Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex"},{"title3":"Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people"},{"title3":"Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: A recent view"},{"title3":"Susceptibility to COVID-19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants"},{"title3":"Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: A prospective cohort study"},{"title3":"Sexual-dimorphism in human immune system aging"},{"title3":"The lethal sex gap: COVID-19"},{"title3":"Coronavirus COV-19/SARS-CoV-2 affects women less than men: Clinical response to viral infection"},{"title3":"What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses"},{"title3":"The role of host defences in Covid 19 and treatments thereof"},{"title3":"Presence of Genetic Variants Among Young Men With Severe COVID-19"},{"title3":"Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing"},{"title3":"Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases"},{"title3":"Genetics of exceptional longevity: Possible role of GM allotypes"},{"title3":"Trained Innate Immunity, Epigenetics, and Covid-19"},{"title3":"SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment"},{"title3":"Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak"},{"title3":"Repurposing Anti-Cancer Drugs for COVID-19 Treatment"},{"title3":"Drug repurposing approach to fight COVID-19"},{"title3":"Drug Repositioning for COVID-19"}]},{"title2":"The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID-19","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy"},{"title3":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19)"},{"title3":"ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study"},{"title3":"Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein"},{"title3":"Polymorphisms in the ACE2 locus associate with severity of COVID-19 infection"},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality"},{"title3":"Association of TNF-alpha G-308 a promoter polymorphism with the course and outcome of COVID-19 patients"},{"title3":"Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study"},{"title3":"Nasopharyngeal shedding of severe acute respiratory syndrome--associated coronavirus is associated with genetic polymorphisms"},{"title3":"A functional synonymous coding variant in theIL1RNGene is associated with survival in septic shock"},{"title3":"Association of IL-10 polymorphism with severity of illness in community acquired pneumonia"},{"title3":"Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia"},{"title3":"Interleukin-6 as a potential biomarker of COVID-19 progression"},{"title3":"Presence of genetic variants among young men with severe COVID-19"},{"title3":"Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?"},{"title3":"Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection"}]},{"title2":"Genetic polymorphisms as multi-biomarkers in Severe Acute Respiratory Syndrome (SARS) by coronavirus infection: a systematic review of candidate gene association studies","References":[{"title3":"Renin-angiotensin-aldosterone system and COVID-19 infection"},{"title3":"Neurological manifestations of coronavirus infections - a systematic review"},{"title3":"Pattern recognition receptors and the host cell death molecular machinery"},{"title3":"Modulating influence on HIV/AIDS by interacting RANTES gene variants"},{"title3":"CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis"},{"title3":"RANTES: a versatile and controversial chemokine"},{"title3":"Hormones and cytokines in childhood obesity"},{"title3":"Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients"},{"title3":"TLR7 and TLR8 differentially activate the IRF and NF-kappaB pathways in specific cell types to promote inflammation"},{"title3":"The global spread of 2019-nCoV: a molecular evolutionary analysis"},{"title3":"The regulation and importance of monocyte chemoattractant protein-1"},{"title3":"Natural killer cells in antiviral defense: function and regulation by innate cytokines"},{"title3":"Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 exon 5"},{"title3":"Association of FcgammaRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression"},{"title3":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review"},{"title3":"Complicaciones neurologicas por coronavirus y COVID-19"},{"title3":"Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells"},{"title3":"Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study"},{"title3":"Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection"},{"title3":"Association of ICAM3 genetic variant with severe acute respiratory syndrome"},{"title3":"CD209 (DC-SIGN) -336A&gt;G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese"},{"title3":"Impact of MBL and MASP-2 gene polymorphism and its interaction on susceptibility to tuberculosis"},{"title3":"Ching J.C., Chan K.Y., Lee E.H., Xu M.S., Ting C.K., So T.M., Sham P.C., Leung G.M., Peiris J.S., Khoo U.S., 2010. Significance of the myxovirus resistance A (MxA) gene -123C&gt;a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection. J. Infect. Dis. 201 (12), 1899-1908. doi:10.1086/652799."},{"title3":"ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome"},{"title3":"The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome"},{"title3":"Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders"},{"title3":"MCP-1 and RANTES are mediators of acute and chronic inflammation"},{"title3":"Ferritin as a marker of severity in COVID-19 patients: a fatal correlation"},{"title3":"Inflammation, atherosclerosis, and coronary artery disease [5] (multiple letters)"},{"title3":"Monocyte chemoattractant protein-1 (MCP-1): An overview"},{"title3":"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome"},{"title3":"The spike protein of SARS-CoV - a target for vaccine and therapeutic development"},{"title3":"Genomewide association study of severe Covid-19 with respiratory failure"},{"title3":"Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes"},{"title3":"Como entender a associacao entre o sistema HLA e as doencas auto-imunes endocrinas"},{"title3":"CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity"},{"title3":"Pathogen recognition by DC-SIGN shapes adaptive immunity"},{"title3":"Serum lactate dehydrogenase isoenzyme and total lactate dehydrogenase values in health and disease, and clinical evaluation of these tests by means of discriminant analysis"},{"title3":"MHC structure and function - antigen presentation. Part 1"},{"title3":"Molecular pathology of emerging coronavirus infections"},{"title3":"More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis"},{"title3":"Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population"},{"title3":"Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment"},{"title3":"Association of SARS susceptibility with single nucleic acid polymorphisms of OASI and MxA genes: a case-control study"},{"title3":"Mannan-binding lectin deficiency - good news, bad news, doesn't matter?"},{"title3":"Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Candidate genes associated with susceptibility for SARS-coronavirus"},{"title3":"Institute, M.E.B., n.d. Numbers of HLA Alleles [WWW Document]. URL https://www.ebi.ac.uk/ipd/imgt/hla/stats.html (accessed 5.11.20)."},{"title3":"Cancer cell metabolism: warburg and beyond"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population"},{"title3":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses"},{"title3":"Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients"},{"title3":"Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population"},{"title3":"The role of genetic polymorphisms in environmental health"},{"title3":"Role of polymorphisms of the inflammatory response genes and DC-SIGNR in genetic susceptibility to SARS and other infections."},{"title3":"Toll-like receptors and innate immunity"},{"title3":"C-C motif chemokine ligand 2 (CCL2) mediates acute lung injury induced by lethal influenza H7N9 virus"},{"title3":"Signaling pathways downstream of pattern-recognition receptors and their cross talk"},{"title3":"CXCL10 and autoimmune diseases"},{"title3":"PI3-Kinase deltagamma catalytic isoforms regulate the Th-17 response in tuberculosis"},{"title3":"The unexpected pleiotropic activities of RANTES"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Coronavirus disease (COVID-19): spectrum of CT findings and temporal progression of the disease"},{"title3":"Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"title3":"Elevated fibrinogen-like protein 2 in TNBS-induced colitis mice: association with Th17 and regulatory T cells"},{"title3":"STrengthening the REporting of genetic association studies (STREGA):an extension of the STROBE statement"},{"title3":"Isolation and characterization of the human DC-SIGN and DC-SIGNR promoters"},{"title3":"The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway"},{"title3":"CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications"},{"title3":"The emerging role of CXCL10 in cancer"},{"title3":"Inhibition of the Fibrinogen-Like Protein 2:FcgammaRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13"},{"title3":"Frequency of RANTES gene polymorphisms and their association with incidence of malaria: a longitudinal study on children in Iganga district, Uganda"},{"title3":"Tumor necrosis factor locus: genetic organisation and biological implications"},{"title3":"Targeting CCL5 in inflammation"},{"title3":"The lectin pathway of the complement system"},{"title3":"VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Role of ICAM-3 in the initial interaction of T lymphocytes and APCs"},{"title3":"Sindrome da resposta inflamatoria sistemica na circulacao extracorporea: papel das interleucinas"},{"title3":"MHC class-II molecules and autoimmunity"},{"title3":"The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese"},{"title3":"Allelic polymorphism of human fcgammariia-h/r131 receptor in american tegumentary leishmaniasis"},{"title3":"COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator?"},{"title3":"Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia"},{"title3":"Fc receptors and immunity to parasites"},{"title3":"Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China."},{"title3":"IP-10 in occupational asthma: review of the literature and case-control study"},{"title3":"An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels"},{"title3":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients"},{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"A variant in the CD209 promoter is associated with severity of dengue disease"},{"title3":"Antiviral actions of interferons"},{"title3":"A estrategia PICO para a construcao da pergunta de pesquisa e busca de evidencias"},{"title3":"Single-nucleotide polymorphisms can cause different structural folds of mRNA"},{"title3":"CCL2, CCL3 and CCL4 gene polymorphisms in pulmonary tuberculosis patients of South India"},{"title3":"Regulatory role of CCL5 (rs2280789) and CXCL10 (rs56061981) gene polymorphisms on intracellular CCL5 and CXCL10 expression in pulmonary tuberculosis"},{"title3":"Inflammatory cytokines in vascular dysfunction and vascular disease"},{"title3":"The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3"},{"title3":"Effect of RANTES gene promoter genotypes in patients with ulcerative colitis"},{"title3":"IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese"},{"title3":"Role of ACE2 gene expression in Renin Angiotensin System and its importance in Covid-19: In Silico Approach"},{"title3":"Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants"},{"title3":"Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection"},{"title3":"The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma"},{"title3":"Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome"},{"title3":"Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study"},{"title3":"Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection"},{"title3":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway"},{"title3":"DC-SIGN (CD209) promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation"},{"title3":"The ACE2 G8790A polymorphism: involvement in Type 2 diabetes mellitus combined with cerebral stroke"},{"title3":"Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China"},{"title3":"MCP-1: Chemoattractant with a role beyond immunity: a review"},{"title3":"Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome"},{"title3":"High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus"},{"title3":"Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Genetic Variation of the human alpha-2-Heremans-Schmid Glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection"},{"title3":"Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B"}]},{"title2":"Effects of host genetic variations on response to, susceptibility and severity of respiratory infections","References":[{"title3":"Impact of host genetics and biological response modifiers on respiratory tract infections"},{"title3":"ACE2 variants underlie interindividual variability and susceptibility to COVID-19 in Italian population"},{"title3":"Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection"},{"title3":"Landscape of X chromosome inactivation across human tissues"},{"title3":"Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17beta-oestradiol-dependent and sex chromosome-independent"},{"title3":"Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis"},{"title3":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Association of cytokine and chemokine gene polymorphisms"},{"title3":"High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus"},{"title3":"CD209 (DC-SIGN)- 336A&amp; G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese"},{"title3":"Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"title3":"Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations"},{"title3":"Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A (H1N1) influenza and A (H7N9) influenza"},{"title3":"A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection"},{"title3":"Surfactant protein B gene polymorphism is associated with severe influenza"},{"title3":"Association between single nucleotide polymorphisms in TLR4, TLR2, TLR9, VDR, NOS2 and CCL5 genes with acute viral bronchiolitis"},{"title3":"Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics"},{"title3":"IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist"},{"title3":"Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation"},{"title3":"Interleukin-10 polymorphism in position-1082 and acute respiratory distress syndrome"},{"title3":"Association of IL-10 polymorphism with severity of illness in community acquired pneumonia"},{"title3":"TLR4/NF-kappaB signaling pathway gene single nucleotide polymorphisms alter gene expression levels and affect ARDS occurrence and prognosis outcomes"},{"title3":"Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism"},{"title3":"Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: Importance in ARDS in septic pediatric critically ill patients"},{"title3":"Tumor necrosis factor-alpha- 308 G/A polymorphism and risk of sepsis, septic shock, and mortality: an updated meta-analysis"},{"title3":"IFN-gamma+ 874 A&amp; T (rs2430561) gene polymorphism and risk of pulmonary tuberculosis: a meta-analysis"},{"title3":"Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis"},{"title3":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis"},{"title3":"Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children"},{"title3":"Polymorphism of HLA class I and class II alleles in influenza A (H1N1) pdm09 virus infected population of Assam, Northeast India"}]},{"title2":"Mapping the human genetic architecture of COVID-19","References":[{"title3":"The COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eu. J. Hum. Genet. 28, 715-718 (2020)."},{"title3":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature600, 472-477 (2021)."},{"title3":"Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis"},{"title3":"New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries"},{"title3":"Human surfactant protein D binds spike protein and acts as an entry inhibitor of SARS-CoV-2 pseudotyped viral particles"},{"title3":"The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins"},{"title3":"Improving the diagnostic yield of exome-sequencing by predicting gene-phenotype associations using large-scale gene expression analysis"},{"title3":"A common MUC5B promoter polymorphism and pulmonary fibrosis"},{"title3":"Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity"},{"title3":"Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis"},{"title3":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors"},{"title3":"Horowitz, J. E. et al. Common genetic variants identify targets for COVID-19 and individuals at high risk of severe disease. Preprint at medRxiv10.1101/2020.12.14.20248176 (2021)."},{"title3":"Immunoregulatory functions of surfactant proteins"},{"title3":"Muc5b is required for airway defence"}]},{"title2":"Whole genome sequencing reveals host factors underlying critical Covid-19","References":[{"title3":"Genetic mechanisms of critical illness in COVID-19"},{"title3":"Genomewide association study of severe Covid-19 with respiratory failure"},{"title3":"Mapping the human genetic architecture of COVID-19"},{"title3":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19"},{"title3":"Features of 20,133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study"},{"title3":"Tissue-specific immunopathology in fatal COVID-19"},{"title3":"Millar, J. E. et al. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study. Sci. Rep.12, 6843 (2022)."},{"title3":"Dexamethasone in hospitalized patients with Covid-19"},{"title3":"Degenhardt, F. et al. New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations. Preprint at medRxiv10.1101/2021.07.21.21260624 (2021)."},{"title3":"Rare loss-of-function variants in type i IFN immunity genes are not associated with severe COVID-19"},{"title3":"Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals"},{"title3":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies"},{"title3":"A simple new approach to variable selection in regression, with application to genetic fine mapping"},{"title3":"CADD: predicting the deleteriousness of variants throughout the human genome"},{"title3":"HIBAG:HLA genotype imputation with attribute bagging"},{"title3":"The influence of HLA genotype on the severity of COVID-19 infection"},{"title3":"Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts"},{"title3":"The mutational constraint spectrum quantified from variation in 141,456 humans"},{"title3":"X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19"},{"title3":"Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study"},{"title3":"Presence of genetic variants among young men with severe COVID-19"},{"title3":"The GTEx Consortium atlas of genetic regulatory effects across human tissues"},{"title3":"Causal associations between risk factors and common diseases inferred from GWAS summary data"},{"title3":"Genomic atlas of the human plasma proteome"},{"title3":"Open source clinical science for emerging infections"},{"title3":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity"},{"title3":"Phospholipid scramblase 1 potentiates the antiviral activity of interferon"},{"title3":"Phospholipid scramblase 1 interacts with influenza a virus NP, impairing its nuclear import and thereby suppressing virus replication"},{"title3":"Repurposed antiviral drugs for Covid-19:interim WHO Solidarity trial results"},{"title3":"Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial"},{"title3":"Bcl11a is essential for lymphoid development and negatively regulates p53"},{"title3":"Plasmacytoid dendritic cells: development, regulation, and function"},{"title3":"Hemokinin is a hematopoietic-specific tachykinin that regulates b lymphopoiesis"},{"title3":"Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production"},{"title3":"Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity"},{"title3":"Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19"},{"title3":"GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches"},{"title3":"A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS"},{"title3":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19"},{"title3":"CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2"},{"title3":"DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist"},{"title3":"Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A"},{"title3":"GCTA: a tool for genome-wide complex trait analysis"},{"title3":"PLINK: a tool set for whole-genome association and population-based linkage analyses"},{"title3":"Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits"},{"title3":"METAL: fast and efficient meta-analysis of genomewide association scans"},{"title3":"How to perform a meta-analysis with R: a practical tutorial"},{"title3":"Fast and accurate imputation of summary statistics enhances evidence of functional enrichment"},{"title3":"Improved analyses of GWAS summary statistics by reducing data heterogeneity and errors"},{"title3":"Sex differences in genetic architecture in the UK biobank"},{"title3":"The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study"},{"title3":"HLA*LA:HLA typing from linearly projected graph alignments"},{"title3":"A gene-based association method for mapping traits using reference transcriptome data"},{"title3":"Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics"},{"title3":"Integrating predicted transcriptome from multiple tissues improves association detection"},{"title3":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics"},{"title3":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression"},{"title3":"The COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur. J. Hum. Genet.28, 715-718 (2020)."},{"title3":"LD score regression distinguishes confounding from polygenicity in genome-wide association studies"},{"title3":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits"},{"title3":"Disease Ontology: a backbone for disease semantic integration"},{"title3":"Gene Ontology: tool for the unification of biology"},{"title3":"KEGG: Kyoto Encyclopedia of Genes and Genomes"},{"title3":"The reactome pathway knowledgebase"},{"title3":"Phospholipid scramblase 1 contains a nonclassical nuclear localization signal with unique binding site in importin alpha"},{"title3":"Nuclear phospholipid scramblase 1 prolongs the mitotic expansion of granulocyte precursors during G-CSF-induced granulopoiesis"},{"title3":"Structural linkage between ligand discrimination and receptor activation by type i interferons"}]},{"title2":"Systematic review of host genetic association with Covid-19 prognosis and susceptibility: what have we learned in 2020?","References":[{"title3":"Years of life lost to COVID-19 in 81 countries"},{"title3":"Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review"},{"title3":"Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis"},{"title3":"Prevalence of underlying diseases in died cases of COVID-19: a systematic review and meta-analysis"},{"title3":"Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis"},{"title3":"COVID-19 gender susceptibility and outcomes: a systematic review"},{"title3":"COVID-19 pandemic: disparate health impact on the hispanic/latinx population in the United States"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Evolution and epidemic spread of SARS-CoV-2 in Brazil"},{"title3":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity"},{"title3":"Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7"},{"title3":"Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics"},{"title3":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2"},{"title3":"Lessons learned: new insights on the role of cytokines in COVID-19"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Quality of genetic association studies (Q-Genie)"},{"title3":"Empirical evaluation of the Q-Genie tool: a protocol for assessment of effectiveness"},{"title3":"HLA genetic polymorphisms and prognosis of patients with COVID-19"},{"title3":"Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. The Sardinian experience"},{"title3":"Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome"},{"title3":"Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility"},{"title3":"The effect of HLA-B27 on susceptibility and severity of COVID-19"},{"title3":"Genomewide association study of severe covid-19 with respiratory failure"},{"title3":"APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort"},{"title3":"Interferon-induced Transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019"},{"title3":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19"},{"title3":"Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. medRxiv  Prepr Serv health Sci."},{"title3":"Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)"},{"title3":"Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19"},{"title3":"HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients"},{"title3":"ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain"},{"title3":"Association between ABO blood group system and COVID-19 susceptibility in Wuhan"},{"title3":"Relationship between the ABO blood group and the COVID-19 susceptibility"},{"title3":"Natural history of coronavirus disease 2019: risk factors for hospitalizations and deaths among &gt;26 million US medicare beneficiaries. J Infect Dis. Published online December 2020"},{"title3":"COVID-19 and sex differences"},{"title3":"Association between upper respiratory tract viral load, comorbidities, disease severity, and outcome of patients with SARS-CoV-2 infection. J Infect Dis"},{"title3":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication"},{"title3":"Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19"},{"title3":"The role of a mutant CCR5 allele in HIV-1 transmission and disease progression"},{"title3":"Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza"},{"title3":"IFITM3: how genetics influence influenza infection demographically"},{"title3":"IFITM3, TLR3, and CD55 gene SNPs and cumulative genetic risks for severe outcomes in Chinese patients with H7N9/H1N1pdm09 influenza"},{"title3":"The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: a review"},{"title3":"Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply"},{"title3":"Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse"},{"title3":"The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic"},{"title3":"Mapping the Human Genetic Architecture of COVID-19 by Worldwide Meta-Analysis"},{"title3":"Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity"},{"title3":"Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals"},{"title3":"Extreme phenotypes approach to investigate host genetics and COVID-19 outcomes"},{"title3":"STrengthening the REporting of genetic association studies (STREGA)- an extension of the STROBE statement"},{"title3":"Genomics is failing on diversity"},{"title3":"Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients"},{"title3":"SARS-CoV-2 viral load, IFNlambda polymorphisms and the course of COVID-19: an observational study"},{"title3":"ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population"},{"title3":"Association of TNF-alpha G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients"}]},{"title2":"Tumour necrosis factor gene polymorphism and disease prevalence","References":[{"title3":"Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization"},{"title3":"Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp"},{"title3":"Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes"},{"title3":"Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors"},{"title3":"The tumor necrosis factor-a promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population"},{"title3":"Is there a future for TNF promoter polymorphisms?"},{"title3":"The -238 and -308G/A polymorphisms of tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians"},{"title3":"Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behcet's disease"},{"title3":"Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease"},{"title3":"Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis"},{"title3":"Polymorphism of the regulatory region of tumor necrosis factor alpha gene in patient with systemic lupus erythematosus"},{"title3":"Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis"},{"title3":"Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor alpha with dermatitis herpetic formis"},{"title3":"Crohn's disease is associated with Novel polymorphisms in the 50-flanking region of the tumor necrosis factor gene"},{"title3":"Single base polymorphism in the human tumor necrosis factor alpha (TNF-alpha) gene detectable by NcoI restriction of PCR product"},{"title3":"The tumor necrosis factor alpha 2238G-A and 2308G-A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type II diabetic patients"},{"title3":"Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes"},{"title3":"Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic"},{"title3":"Is susceptibility to tuberculosis acquired or inherited?"},{"title3":"Tuberculosis in twins a re-analysis of the Prophit survey"},{"title3":"Genetic susceptibility to mycobacterial disease in humans"},{"title3":"Human genetic susceptibility to tuberculosis and other mycobacterial diseases"},{"title3":"Genetic susceptibility to tuberculosis"},{"title3":"Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians"},{"title3":"Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF alpha levels"},{"title3":"Interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in tuberculosis"},{"title3":"Polymorphisms of interleukin-10 and tumour necrosis factor-alpha genes are associated with newly diagnosed and recurrent pulmonary tuberculosis"},{"title3":"Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis"},{"title3":"Genetic polymorphisms in alveolar macrophage response-related genes, and risk of silicosis and pulmonary tuberculosis in Chinese iron miners"},{"title3":"IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy"},{"title3":"Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes"},{"title3":"NRAMP1 and TNF-alpha polymorphisms and susceptibility to tuberculosis in Thais"},{"title3":"Genetic polymorphisms in TNF genes and tuberculosis in North Indians"},{"title3":"Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases"},{"title3":"Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy"},{"title3":"Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes"},{"title3":"Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil"},{"title3":"Single nucleotide polymorphisms (SNPs) at -238 and -308 positions in the TNFalpha promoter: clinical and bacteriological evaluation in leprosy"},{"title3":"Functional analysis of a human tumour necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis"},{"title3":"An investigation of polymorphism in the interleukin-10 gene promoter"},{"title3":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis"},{"title3":"Patterns of proinflammatory cytokines and inhibitors during typhoid fever"},{"title3":"A TNF region haplotype offers protection from typhoid fever in Vietnamese patients"},{"title3":"Genome scale DNA methylation maps of pluripotent and differentiated cells"},{"title3":"Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a link to insulin dependent diabetes mellitus"},{"title3":"Treating patients with severe sepsis"},{"title3":"Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality"},{"title3":"Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles"},{"title3":"Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever"},{"title3":"Association of TNF-promoter polymorphisms with the clearance of hepatitis B virus infection"},{"title3":"Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B"},{"title3":"Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study"},{"title3":"Severity of Human African Trypanosomiasis in East Africa Is Associated with Geographic Location, Parasite Genotype, and Host Inflammatory Cytokine Response Profile"},{"title3":"TNF-alpha expression and promoter sequences reflect the balance of tolerance/resistance to Puumala hantavirus infection in European bank vole populations"},{"title3":"Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar"},{"title3":"Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX"},{"title3":"Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand"},{"title3":"Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population"},{"title3":"Lack of association between -308 tumor necrosis factor polymorphism and susceptibility to cerebral malaria among Central Sudanese children"},{"title3":"TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients"},{"title3":"TNF polymorphism and cardiovascular disease: TNF gene polymorphism and quantitative traits related to cardiovascular disease: getting to the heart of the matter"},{"title3":"TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization"},{"title3":"Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women"},{"title3":"Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity"},{"title3":"Five polymorphisms and breast cancer risk: results from the breast cancer association consortium"},{"title3":"TNF superfamily gene polymorphism as prognostic factor in early breast cancer"},{"title3":"TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer"},{"title3":"TNF polymorphisms and prostate cancer risk"},{"title3":"Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95"},{"title3":"Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma"},{"title3":"Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer"},{"title3":"Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma"},{"title3":"Study on the relationship between tumour necrosis factor gene polymorphism and prognosis in the patients with renal cell carcinoma"},{"title3":"G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study"},{"title3":"Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis"},{"title3":"Cystic fibrosis conductance regulator, tumor necrosis factor, interferon alpha-10, interferon alpha-17, and interferon gamma genotyping as potential risk markers in pulmonary sarcoidosis pathogenesis in Greek patients"},{"title3":"TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients"},{"title3":"Tumour necrosis factor haplotypes and asthma"},{"title3":"TNF-alpha promoter polymorphisms, production, and susceptibility to multiple sclerosis in different groups of patients"},{"title3":"TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients"},{"title3":"Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?"},{"title3":"Tumor necrosis factor-alpha promoter -308A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis"},{"title3":"Polymorphisms of tumor necrosis factor-alpha promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population"},{"title3":"Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis"},{"title3":"Tumor necrosis factor alpha (TNF-alpha) polymorphisms in Chinese patients with Graves' disease"},{"title3":"The Type 1 Diabetes Genetics Consortium"},{"title3":"Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group Genetic mapping at 3-kilobase resolution reveais inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden"},{"title3":"A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region"},{"title3":"Association between G-308A polymorphism of the tumor necrosis factor-alpha gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents"},{"title3":"Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India"},{"title3":"Association of -308TNF-alpha promoter polymorphism with type 1 diabetes in North Indians"},{"title3":"Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility"},{"title3":"No primary association between the -308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus"},{"title3":"Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population"},{"title3":"Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility"},{"title3":"Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes the Finnish Diabetes Prevention Study"},{"title3":"Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy"},{"title3":"Linkage of inflammatory bowel disease to human chromosome 6p"},{"title3":"Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)"},{"title3":"Genome wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci"},{"title3":"Genetic influence on cytokine production and fatal meningococcal disease"},{"title3":"Independent contributions of HLA-DRB1 and TNF-alpha promoter polymorphisms to the susceptibility of Crohn's disease"},{"title3":"Association between tumor necrosis factor-alpha and Fc-gamma receptor polymorphisms with infliximab in Crohn's disease"},{"title3":"Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma"},{"title3":"Association between alpha-308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma"},{"title3":"Tumour necrosis factor gene polymorphism and childhood wheezing"},{"title3":"The association between tumor necrosis factor alpha gene polymorphism and asthma"},{"title3":"Candidate genetic polymorphisms for asthma in Chinese schoolchildren from Hong Kong"},{"title3":"Relationship between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma"},{"title3":"Association of the TNF-alpha-308 (G A) polymorphism with self-reported history of childhood asthma"},{"title3":"Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-alpha-308 and lymphotoxin-alpha-NcoI in Taiwan's children"},{"title3":"Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene"},{"title3":"Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma"},{"title3":"Lack of association between atopic asthma and the tumor necrosis factor alpha-308 gene polymorphism in a Czech population"},{"title3":"Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses"},{"title3":"Association of tumor necrosis factor polymorphisms with asthma and serum total IgE"},{"title3":"Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis"},{"title3":"Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction"},{"title3":"Mapping the HLA association in Behcet's disease. A role for tumor necrosis factor polymorphisms?"},{"title3":"Influence of tumour necrosis factor-alpha polymorphism -308 and atopy on irritant contact dermatitis in healthcare workers"},{"title3":"TNF-alpha gene promoter -238G&gt;A and -308G&gt;A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis"},{"title3":"Psoriasis induced by tumor necrosis factor-a antagonist therapy: a case series"},{"title3":"Impact of cytokine genotype on cardiovascular surrogate markers in hemodialysis patients"},{"title3":"Association of TNF-alpha gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study"},{"title3":"The Genetic Architecture of Intracerebral Hemorrhage"},{"title3":"Association between Tumor Necrosis Factor-Alpha (-308G A and -238G A) Polymorphisms and Homocysteine Levels in Patients with Ischemic Strokes and Silent Brain Infarctions"},{"title3":"TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels"},{"title3":"Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population"},{"title3":"Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease"},{"title3":"Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort"},{"title3":"Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system"},{"title3":"Tumor necrosis factor-alpha mediates one component of competitive, experience- dependent plasticity in developing cortex"},{"title3":"Evidence for a cytokine model of cognitive function"},{"title3":"Association between genetic variants of IL-beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study"},{"title3":"Associations between the tumor necrosis factor alpha gene (-308G A) and event-related potential indices of attention and mental rotation"},{"title3":"Labile anger during interferon alpha treatment is associated with a polymorphism in Tumor Necrosis Factor alpha"},{"title3":"TNF-alpha and neuropathic pain"},{"title3":"Tumor Necrosis Factor-alpha 238G&gt;A Promoter Polymorphism Is Associated with Increased Risk of New Hemorrhage in the Natural Course of Patients with Brain Arteriovenous Malformations"},{"title3":"Is there a genetic basis to endometriosis?"},{"title3":"TNF promoter polymorphisms associated with muscle phenotypes in humans"},{"title3":"Paget's disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8, and tumor necrosis factor alpha genes"},{"title3":"A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: the retina 4 project"},{"title3":"Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus"},{"title3":"Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage"},{"title3":"TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in italian women"},{"title3":"The Fundamental Role of Epigenetic Events in Cancer"},{"title3":"Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter"},{"title3":"Methylation-induced repression-belts, braces, and chromatin"},{"title3":"DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution"},{"title3":"Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome"},{"title3":"DNA methylation profiling of human chromosomes 6, 20 and 22"},{"title3":"DNA Methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia"},{"title3":" In silico detection of sequence variations modifying transcriptional regulation"},{"title3":"Structural and functional analysis of a new upstream promoter of the human FAT/CD36 gene"},{"title3":"A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus"},{"title3":"An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels"},{"title3":"A Common functional polymorphism (C A substitution at position -863) in the promoter region of tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha"},{"title3":" TNF-alpha 857T, a genetic risk marker for acute anterior uveitis"},{"title3":"Variable Transcription Factor Binding: a Mechanism of Evolutionary Change"},{"title3":"Binding site turnover produces pervasive quantitative changes in transcription factor binding between closely related Drosophila species"},{"title3":"HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC"},{"title3":"Species-specific transcription in mice carrying human chromosome 21"},{"title3":"Regulatory divergence in Drosophila melanogaster and D. simulans a genome-wide analysis of allele-specific expression"},{"title3":"A yeast hybrid provides insight into the evolution of gene expression regulation"},{"title3":"The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis"},{"title3":"Acute otitis media severity: Association with cytokine gene polymorphisms and other risk factors"},{"title3":"Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media"},{"title3":"Relation of a TNF gene polymorphism to severe sepsis in trauma patients"},{"title3":"NRAMP1 and TNF-alpha polymorphisms and susceptibility to tuberculosis in Thais"},{"title3":"Goldberg AC Lack of association of tumour necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients"},{"title3":"Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis"},{"title3":"Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus"},{"title3":"Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest"}]},{"title2":"TNF-alpha gene polymorphisms and expression","References":[{"title3":"Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease"},{"title3":"The potential biological and clinical significance of the soluble tumor necrosis factor receptors"},{"title3":"The -308 G/A polymorphism in the tumor necrosis factor-alpha gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients"},{"title3":"Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients"},{"title3":"Comparison of serum IL-1beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis"},{"title3":"Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective"},{"title3":"Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes"},{"title3":"Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians"},{"title3":"Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis"},{"title3":"Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis"},{"title3":"Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. BBA"},{"title3":"Polymorphisms of tumor necrosis factor-alpha promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population"},{"title3":"Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis"},{"title3":"Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes"},{"title3":"Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis"},{"title3":"Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes"},{"title3":"AUF1 binding affinity to A + U-rich elements correlates with rapid mRNA degradation"},{"title3":"Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity"},{"title3":"Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease"},{"title3":"Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis"},{"title3":"Cytokine production in the rheumatoid joint: implications for treatment"},{"title3":"Angiotensin II induces TNF production by the thick ascending limb: functional implications"},{"title3":"Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter"},{"title3":"Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population"},{"title3":"Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level"},{"title3":"No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis"},{"title3":"Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease"},{"title3":"Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA"},{"title3":"A systems biology approach to suppress TNF-induced proinflammatory gene expressions"},{"title3":"Two distinct regions in the 3' untranslated region of tumor necrosis factor alpha mRNA form complexes with macrophage proteins"},{"title3":"Characterization of the RNA binding proteins forming complexes with a novel putative regulatory region in the 3'-UTR of TNF-alpha mRNA"},{"title3":"Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappaB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis"},{"title3":"Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese"},{"title3":"Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes"},{"title3":"TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients"},{"title3":"Mast cell tumor necrosis factor alpha production is regulated by MEK kinases"},{"title3":"Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population"},{"title3":"Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism"},{"title3":"Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective"},{"title3":"Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort"},{"title3":"Angiotensin II and gene expression in the kidney"},{"title3":"IRF5 is required for late-phase TNF secretion by human dendritic cells"},{"title3":"Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis"},{"title3":"Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility"},{"title3":"Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis"},{"title3":"The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis"},{"title3":"Association of TNF-alpha gene polymorphisms with the risk of rheumatoid arthritis in Han Chinese population from Hunan"},{"title3":"Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients"},{"title3":"Targeting the PIAS1 SUMO ligase pathway to control inflammation"},{"title3":"The TNF and TNF receptor superfamilies: integrating mammalian biology"},{"title3":"Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network"},{"title3":"Inhibition of constitutive TNF production is associated with PACAP-mediated differentiation in PC12 cells"},{"title3":"Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis"},{"title3":"TNF-alpha promoter gene polymorphisms in Spanish children with persistent oligoarticular and systemic-onset juvenile idiopathic arthritis"},{"title3":"Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis"},{"title3":"Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris"},{"title3":"TNF-alpha genetic polymorphisms and its expression in Egyptian rheumatoid arthritis patients"},{"title3":"TNF-alpha gene polymorphisms: association with disease susceptibility and response to anti-TNF-alpha treatment in psoriatic arthritis"},{"title3":"Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population"},{"title3":"Tumor Necrosis factor-alpha promoter -308/238 polymorphism association with less severe disease in Ankylosing Spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response"},{"title3":"Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance"},{"title3":"Can tumor necrosis factor receptor II gene 676T &gt; G polymorphism predict the response grading to anti-TNFalpha therapy in rheumatoid arthritis?"},{"title3":"Tumour necrosis factor alpha G   A - 238 and G   A - 308 polymorphisms in juvenile idiopathic arthritis"},{"title3":"Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid"},{"title3":"TNF-308 G/A polymorphism and risk of systemic lupus erythematosus in the Polish population"},{"title3":"Relation of HLA-B27, tumor necrosis factor-alpha promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis:a comprehensive genotype-phenotype analysis from an observational cohort"},{"title3":"TNFalpha polymorphisms and risk of psoriatic arthritis"},{"title3":"Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis"},{"title3":"Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans"},{"title3":"TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus"},{"title3":"Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism"},{"title3":"Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappaB activation and monocyte chemoattractant protein-1 synthesis"},{"title3":"Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan"},{"title3":"Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus"},{"title3":"A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans"},{"title3":"Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK"},{"title3":"A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNFAalpha) locus"},{"title3":"No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes"},{"title3":"Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kappaB transcription factors"},{"title3":"Tumor necrosis factor-alpha promoter polymorphisms in mexican patients with spondyloarthritis"},{"title3":"Study on the association between tumor necrosis factor alpha gene polymorphism and systemic lupus erythematosus"},{"title3":"Mitogen-activated Protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells indications of communication between p38 and p42 Map kinases"},{"title3":"Association between TNF alpha gene polymorphisms and the risk of duodenal ulcer: a meta-analysis"},{"title3":"Regulation of TNF expression by multiple mitogen-activated protein kinase pathways"},{"title3":"Adenosine-cyclic AMP pathways and cytokine expression"},{"title3":"Meta-analysis of TNF-alpha promoter-308A/G polymorphism and SLE susceptibility in Asian populations"}]},{"title2":"The effects of Tumor Necrosis Factor-alpha (TNF-alpha) rs1800629 and rs361525 polymorphisms on sepsis risk","References":[{"title3":"Sepsis and immunosenescence in the elderly patient: a review"},{"title3":"Sepsis: frontiers in supportive care, organisation and research"},{"title3":"Mass spectrometry for the discovery of biomarkers of sepsis"},{"title3":"Sepsis and septic shock"},{"title3":"The relationship between toll like receptor 4 gene rs4986790 and rs4986791 polymorphisms and sepsis susceptibility: a meta-analysis"},{"title3":"SERPINE1 rs1799768 polymorphism contributes to sepsis risk and mortality"},{"title3":"The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: a systematic review and meta-analysis"},{"title3":"TNF-alpha gene polymorphisms and expression"},{"title3":"TNF-alpha and cancer cachexia: molecular insights and clinical implications"},{"title3":"TNFerade, an innovative cancer immunotherapeutic"},{"title3":"TNF as a malaria candidate gene: polymorphism-screening and family-based association analysis of mild malaria attack and parasitemia in Burkina Faso"},{"title3":"Clinical relevance of single nucleotide polymorphisms within the 13 cytokine genes in North Indian trauma hemorrhagic shock patients"},{"title3":"Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients"},{"title3":"Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality"},{"title3":"Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis"},{"title3":"Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis"},{"title3":"Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants"},{"title3":"Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients"},{"title3":"Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease?"},{"title3":"The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis"},{"title3":"Study on the relationships between tumor necrosis factor polymorphisms and sepsis susceptibility and factor productivity"},{"title3":"Tumor necrosis factor alpha gene polymorphism is associated with the outcome of trauma patients in Chinese Han population"},{"title3":"Correlation of TNF-alpha gene polymorphisms with sepsis susceptibility"},{"title3":"TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study"},{"title3":"Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients"},{"title3":"Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study"},{"title3":"The G--&gt;A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma"},{"title3":"Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina"},{"title3":"Genetic association study of tumor necrosis factor-alpha with sepsis and septic shock in Thai pediatric patients"},{"title3":"Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism"},{"title3":"Genetic variability in the severity and outcome of community-acquired pneumonia"},{"title3":"Relationships of TNF-alpha gene polymorphism with susceptibility to sepsis and its infections degrees"},{"title3":"The associations of the single nucleotide polymorphisms on TNF and CD14 promoters with the mortality of infection, systematic inflammatory response syndromec and sepsis in surgical patients"},{"title3":"Association between gene polymorphisms of tumor necrosis factor and the susceptibility and prognosis of severe sepsis"},{"title3":"Systematic review and meta-analysis: gene association studies in neonatal sepsis"},{"title3":"Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis"},{"title3":"Tumor necrosis factor-alpha -308G/A and -238G/A polymorphisms are associated with increased risks of sepsis: evidence from an updated meta-analysis"},{"title3":"Association of tumor necrosis factor-2 allele with plasma tumor necrosis factor-alpha levels and mortality from septic shock"},{"title3":"TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury"},{"title3":"Influence of the TNF-alpha and TNF-beta polymorphisms upon infectious risk and outcome in surgical intensive care patients"},{"title3":"[Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism in surgical intensive care patients with SIRS]. [Article in German]"},{"title3":"Association of IL-10 polymorphism with severity of illness in community acquired pneumonia"},{"title3":"Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis"},{"title3":"Cytokine gene promoter polymorphisms and mortality in acute renal failure"},{"title3":"Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis"},{"title3":"Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications"},{"title3":"Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor"},{"title3":"Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis"},{"title3":"-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter"},{"title3":"Tumor necrosis factor gene polymorphism and septic shock in surgical infection"},{"title3":"Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications"},{"title3":"Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations"},{"title3":"Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis"},{"title3":"Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis"},{"title3":"Neonatal infections in Saudi Arabia: association with cytokine gene polymorphisms"},{"title3":"TNF-alpha, IL-6, and IL-8 cytokines and their association with TNF-alpha-308 G/A polymorphism and postoperative sepsis"},{"title3":"Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock"},{"title3":"TNF -308G &gt; A promoter polymorphism (rs1800629) and outcome from critical illness"},{"title3":"Genome-wide expression profiles in very low birth weight infants with neonatal sepsis"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Updated meta-analysis of the role of APOE epsilon2/epsilon3/epsilon4 alleles in frontotemporal lobar degeneration"},{"title3":"Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis"},{"title3":"A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibility"}]},{"title2":"Tumor necrosis factor -308 polymorphism (rs1800629) is associated with mortality and ventilator duration in 1057 Caucasian patients","References":[{"title3":"Multiple organ failure in polytrauma patients"},{"title3":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care"},{"title3":"Association between tumor necrosis factor-alpha promoter -308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: a systematic review and meta-analysis"},{"title3":"Genomic polymorphisms in sepsis"},{"title3":"Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?"},{"title3":"Genetic polymorphisms and sepsis"},{"title3":"A bias-ed assessment of the use of SNPs in human complex traits"},{"title3":"A systematic review of the quality of genetic association studies in human sepsis"},{"title3":"Genetic variability and outcome in the critically ill: avoiding SNP judgments"},{"title3":"Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and age"},{"title3":"Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},{"title3":"Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome"},{"title3":"Long-term mortality and medical care charges in patients with severe sepsis"},{"title3":"Performing the exact test of Hardy-Weinberg proportion for multiple alleles"},{"title3":"Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria"},{"title3":"The pathophysiology and treatment of sepsis"},{"title3":"Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis"},{"title3":"Outcome prediction in sepsis combined use of genetic polymorphisms - a study in Japanese population"},{"title3":"Population genetics in critical illness"},{"title3":"Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals"},{"title3":"Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications"},{"title3":"Molecular biology on the ICU. From understanding to treating sepsis"},{"title3":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation"},{"title3":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent"},{"title3":"Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis"},{"title3":"Gene-specific control of inflammation by TLR-induced chromatin modifications"},{"title3":"Endotoxin tolerance: new mechanisms, molecules and clinical significance"},{"title3":"Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms"},{"title3":"Management of sepsis"},{"title3":"Cell death"},{"title3":"Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations"},{"title3":"Variation in the TLR4 gene influences the risk of organ failure and shock post trauma: a cohort study"},{"title3":"Clinical application of cytokine-related gene polymorphism analysis using a newly developed DNA chip in critically ill patients"},{"title3":"Injury in the era of genomics"},{"title3":"Clinical assessment incorporating a personal genome"}]},{"title2":"Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease","References":[]},{"title2":"Association of genetic polymorphisms in DC-SIGN, toll-like receptor 3, and tumor necrosis factor alpha genes and the Lewis-negative phenotype with chikungunya infection and disease in Nicaragua","References":[]},{"title2":"Meta-analysis of the relationship between TNF-alpha (-308G/A) and IL-10 (-819C/T) gene polymorphisms and susceptibility to dengue","References":[]},{"title2":"Polymorphism of tumor necrosis factor-alpha and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated interferon-alpha therapy response","References":[]},{"title2":"Genetic influences on viral-induced cytokine responses in the lung","References":[{"title3":"Makris, S., Paulsen, M. &amp; Johansson, C. Type I interferons as regulators of lung inflammation. Front. Immunol. 8, 259 (2017)."},{"title3":"Influenza virus-related critical illness: pathophysiology and epidemiology"},{"title3":"Regulating the adaptive immune response to respiratory virus infection"},{"title3":"Innate immunity to influenza virus infection"},{"title3":"Severe viral respiratory infections in children with IFIH1 loss-of-function mutations"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Human coronavirus NL63 associated with lower respiratory tract symptoms in early life"},{"title3":"Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients"},{"title3":"Forum of International Respiratory Societies. The Global Impact of Respiratory Disease 2nd ed (European Respiratory Society, 2017)."},{"title3":"Influenza"},{"title3":"The pathogenesis of influenza virus infections: the contributions of virus and host factors"},{"title3":"Avian influenza A (H5N1) infection in humans"},{"title3":"Ramos, I. &amp; Fernandez-Sesma, A. Modulating the innate immune response to influenza a virus: potential therapeutic use of anti-inflammatory drugs. Front. Immunol. 6, 361 (2015)."},{"title3":"Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia"},{"title3":"Inflammatory cytokines in the BAL of patients with ARDS"},{"title3":"Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection"},{"title3":"Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1)"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Cole, S. L. et al. M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. JCI Insight2, e91868 (2017)."},{"title3":"Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice"},{"title3":"Animal models for influenza virus pathogenesis and transmission"},{"title3":"Immunity to respiratory viruses"},{"title3":"Host and viral determinants of influenza A virus species specificity"},{"title3":"Pathogenic potential of interferon alphabeta in acute influenza infection"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus"},{"title3":"Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes"},{"title3":"Klinkhammer, J. et al. IFN-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife7, e33354 (2018)."},{"title3":"Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo"},{"title3":"Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection"},{"title3":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis"},{"title3":"A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis"},{"title3":"Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung"},{"title3":"Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology"},{"title3":"Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology"},{"title3":"Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection"},{"title3":"Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus"},{"title3":"Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules"},{"title3":"Regulation of tumour necrosis factor signalling: live or let die"},{"title3":"Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10"},{"title3":"IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge"},{"title3":"A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection"},{"title3":"Timed action of IL-27 protects from immunopathology while preserving defense in influenza"},{"title3":"CD4+ T cell help and innate-derived IL-27 induce blimp-1-dependent IL-10 production by antiviral CTLs"},{"title3":"IL-37 is a fundamental inhibitor of innate immunity"},{"title3":"Qi, F. et al. Interleukin-37 ameliorates influenza pneumonia by attenuating macrophage cytokine production in a MAPK-dependent manner. Front. Microbiol. 10, 2482 (2019)."},{"title3":"CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality"},{"title3":"TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza:streptococcus pneumoniae coinfection"},{"title3":"Functional Interplay between type I and II interferons is essential to limit influenza A virus-induced tissue inflammation"},{"title3":"TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection"},{"title3":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection"},{"title3":"The human immune response to respiratory syncytial virus infection"},{"title3":"Protective and harmful immunity to RSV infection"},{"title3":"Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis"},{"title3":"Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system"},{"title3":"Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease"},{"title3":"Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo"},{"title3":"The histopathology of fatal untreated human respiratory syncytial virus infection"},{"title3":"The role of Th17 and Treg responses in the pathogenesis of RSV infection"},{"title3":"Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice"},{"title3":"IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice"},{"title3":"Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection"},{"title3":"Pulmonary Vgamma4 + gammadelta T cells have proinflammatory and antiviral effects in viral lung disease"},{"title3":"IL-17-producing gammadelta T cells"},{"title3":"Interleukin 33 is a guardian of barriers and a local alarmin"},{"title3":"Respiratory syncytial virus disease is mediated by age-variable IL-33"},{"title3":"Cytokine elevation in sudden death with respiratory syncytial virus: a case report of 2 children"},{"title3":"Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology"},{"title3":"IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis"},{"title3":"Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection"},{"title3":"Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes"},{"title3":"Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development"},{"title3":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Gralinski, L. E. et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. MBio9, e01753-18 (2018)."},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"COVID-19: immunopathology and its implications for therapy"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Israelow, B. et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J. Exp. Med. 217, e20201241 (2020)."},{"title3":"Influenza A viruses: new research developments"},{"title3":"Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens"},{"title3":"Helicobacter pylori infection: genetic and environmental influences: a study of twins"},{"title3":"Genetic and environmental influences on premature death in adult adoptees"},{"title3":"Evidence for a heritable predisposition to death due to influenza"},{"title3":"The genetic theory of infectious diseases: a brief history and selected illustrations"},{"title3":"Severe infectious diseases of childhood as monogenic inborn errors of immunity"},{"title3":"Primary immunodeficiencies of protective immunity to primary infections"},{"title3":"Immunity to microbes: lessons from primary immunodeficiencies"},{"title3":"A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations"},{"title3":"Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency"},{"title3":"Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia"},{"title3":"Viral infections in interferon-gamma receptor deficiency"},{"title3":"Evolution, revolution and heresy in the genetics of infectious disease susceptibility"},{"title3":"Host susceptibility to severe influenza A virus infection"},{"title3":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls"},{"title3":"Host single nucleotide polymorphisms modulating influenza A virus disease in humans"},{"title3":"Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection"},{"title3":"Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus"},{"title3":"CCR5 deficiency predisposes to fatal outcome in influenza virus infection"},{"title3":"The CCR5Delta32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population"},{"title3":"Human CCR5Delta32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period"},{"title3":"Human genetic determinants of viral diseases"},{"title3":"Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families"},{"title3":"A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children"},{"title3":"Respiratory syncytial virus infection and recurrent wheezing in Chilean infants: a genetic background?"},{"title3":"Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes"},{"title3":"Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility"},{"title3":"The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness"},{"title3":"Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults"},{"title3":"Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster"},{"title3":"Junttila, I. S. Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes. Front. Immunol. 9, 888 (2018)."},{"title3":"Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes"},{"title3":"An investigation of polymorphism in the interleukin-10 gene promoter"},{"title3":"Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis"},{"title3":"The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese"},{"title3":"A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma"},{"title3":"Pathogen recognition and inflammatory signaling in innate immune defenses"},{"title3":"Recognition of microorganisms and activation of the immune response"},{"title3":"Pathogen recognition and innate immunity"},{"title3":"Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children"},{"title3":"IFITM3, TLR3, and CD55 gene SNPs and cumulative genetic risks for severe outcomes in chinese patients With H7N9/H1N1pdm09 influenza"},{"title3":"Defective RNA sensing by RIG-I in severe influenza virus infection"},{"title3":"p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus"},{"title3":"Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children"},{"title3":"Association between single nucleotide polymorphisms in TLR4, TLR2, TLR9, VDR, NOS2 and CCL5 genes with acute viral bronchiolitis"},{"title3":"Forbester, J. L. et al. IRF5 promotes influenza virus-induced inflammatory responses in human induced pluripotent stem cell-derived myeloid cells and murine models. J. Virol. 94, e00121-20 (2020)."},{"title3":"Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease"},{"title3":"Advances and challenges in targeting IRF5, a key regulator of inflammation"},{"title3":"Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency"},{"title3":"Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency"},{"title3":"The discovery of the antiviral resistance gene Mx: a story of great ideas, great failures, and some success"},{"title3":"Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import"},{"title3":"Mx genes: host determinants controlling influenza virus infection and trans-species transmission"},{"title3":"Colomer-Lluch, M., Ruiz, A., Moris, A. &amp; Prado, J. G. Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1. Front. Immunol. 9, 2876 (2018)."},{"title3":"IFITM3: how genetics influence influenza infection demographically"},{"title3":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus"},{"title3":"SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans"},{"title3":"IFITM3 restricts the morbidity and mortality associated with influenza"},{"title3":"Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals"},{"title3":"Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection"},{"title3":"IFITM3 and severe influenza virus infection. No evidence of genetic association"},{"title3":"Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: a meta-analysis"},{"title3":"Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019"},{"title3":"Lack of truncated IFITM3 transcripts in cells homozygous for the rs12252-C variant that is associated with severe influenza infection"},{"title3":"Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection"},{"title3":"Modeling host genetic regulation of influenza pathogenesis in the collaborative cross"},{"title3":"Genetically diverse CC-founder mouse strains replicate the human influenza gene expression signature"},{"title3":"Inter-individual variation in health and disease associated with pulmonary infectious agents"},{"title3":"A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection"},{"title3":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors"},{"title3":"Induced pluripotent stem cell technology: a decade of progress"},{"title3":"Humanity in a dish: population genetics with iPSCs"},{"title3":"Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells"},{"title3":"Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells"},{"title3":"CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus"},{"title3":"Genome editing in patient iPSCs corrects the most prevalent USH2A mutations and reveals intriguing mutant mRNA expression profiles"}]},{"title2":"Genetic polymorphism of toll-like receptor 4 Thr399Ile variant in Iraqi Kurdish population: sulaymaniyah province","References":[]},{"title2":"Association of Apolipoprotein e polymorphism with SARS-CoV-2 infection","References":[{"title3":"Frequencies of Apolipoprotein E polymorphism in Iraqi Kurdish population"},{"title3":"Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort"},{"title3":"Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature"},{"title3":"Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae"},{"title3":"Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19"},{"title3":"Residence, clinical features, and genetic risk factors associated with symptoms of COVID-19 in a cohort of older people in Madrid"},{"title3":"Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study"},{"title3":"Interrelations between COVID-19 and other disorders"},{"title3":"New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis"},{"title3":"Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data"},{"title3":"Apolipoprotein E4 allele in subjects with COVID-19"},{"title3":"Gender differences in patients with COVID-19: focus on severity and mortality"},{"title3":"Genetic association analysis of SARS-CoV-2 infection in 455,838 UK Biobank participants 1"},{"title3":"Apolipoprotein e genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review"},{"title3":"APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort"},{"title3":"ApoE e4e4 genotype and mortality with COVID-19 in UK biobank"},{"title3":"Apolipoprotein e gene polymorphism and the risk of cardiovascular disease and type 2 diabetes"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Genetic Polymorphism of Toll-Like Receptor 4 Thr399Ile Variant in Iraqi Kurdish Population: Sulaymaniyah Province."},{"title3":"Simple sequence-specific-primer-PCR method to identify the three main apolipoprotein E haplotypes"},{"title3":"Apolipoprotein E polymorphism and Alzheimer's disease"},{"title3":"Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo"},{"title3":"Host genetic factors and susceptibility to SARS-CoV-2 infection"},{"title3":"Apolipoprotein E4: an allele associated with many diseases"},{"title3":"COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US"},{"title3":"ApoE-isoform-dependent SARS-CoV-2 Neurotropism and cellular response"},{"title3":"WHO Director-General's Opening Remarks at the Media Briefing on COVID-19 - 11 March 2020"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis"},{"title3":"Strong correlation between the case fatality rate of COVID-19 and the rs6598045 single nucleotide polymorphism (SNP) of the interferon-induced transmembrane protein 3 (IFITM3) gene at the population-level"},{"title3":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis"}]},{"title2":"Association of TNF-alpha G-308 a promoter polymorphism with the course and outcome of COVID-19 patients","References":[{"title3":"Cytokine gene polymorphism in human disease: on-line databases"},{"title3":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry"},{"title3":"The immunology of macrophage activation syndrome"},{"title3":"Proinflammatory cytokines"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"},{"title3":"COVID-19: the new challenge for rheumatologists"},{"title3":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel middle east respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Age related human T cell subset evolution and senescence"},{"title3":"Molecular immune pathogenesis and diagnosis of COVID-19"},{"title3":"Can we use interleukin-6 (Il-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?"},{"title3":"Dietary supplementation with omega-3- polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals"},{"title3":"Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Outcomes in patients with severe COVID-19 disease treated with tocilizumab. A case-controlled study"},{"title3":"COVID-19: combining antiviral and anti-inflammatory treatments"},{"title3":"A highly polymorphic CA repeat marker at the human tumor necrosis factor alpha (TNFAalpha) locus"},{"title3":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up"},{"title3":"Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome"},{"title3":"CD28 T cells: their role in the age-associated decline of immune function"},{"title3":"Genetic influence on cytokine production in meningococcal disease"},{"title3":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation"},{"title3":"CD8 T cell responses to infectious pathogens"},{"title3":"The role of TNF alpha polymorphism and expression in susceptibility to nasal polyposis"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality","References":[{"title3":"A Novel coronavirus outbreak of global health concern"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"WHO Coronavirus Disease (COVID-19)"},{"title3":"An inflammatory cytokine signature predicts COVID-19 severity and survival"},{"title3":"Characterization of the inflammatory response to severe COVID-19 illness"},{"title3":"Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: Systematic review with meta-analysis"},{"title3":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis"},{"title3":"Severe SARS-CoV-2 Patients Develop a Higher Specific T-Cell Response"},{"title3":"Multi-Omics Resolves a Sharp Disease-State Shift Between Mild and Moderate COVID-19"},{"title3":"Tumor Necrosis Factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the Severe-Scute Respiratory Syndrome-Coronavirus (SARS-CoV) receptor, Angiotensin-Converting Enzyme-2 (ACE2)"},{"title3":"Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections"},{"title3":"Viral mimicry of cytokines, chemokines and their receptors"},{"title3":"Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation"},{"title3":"Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor"},{"title3":"Inhibition of Tumor Necrosis Factor reduces the severity of virus-specific lung immunopathology"},{"title3":"Trials of anti-Tumour Necrosis Factor therapy for COVID-19 are urgently needed"},{"title3":"Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort"},{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis"},{"title3":"Obesity in Mexico: Rapid Epidemiological Transition and Food Industry Interference in Health Policies"},{"title3":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"title3":"Tumor Necrosis Factor Signaling"},{"title3":"Shedding Light on ADAM Metalloproteinases"},{"title3":"ADAM-17: The enzyme that does it all"},{"title3":"TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling"},{"title3":"A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3)"},{"title3":"The Rheumatology Drugs for COVID-19 Management: Which and When?"},{"title3":"Is a &quot;Cytokine Storm&quot; relevant to COVID-19?"},{"title3":"Cytokine storm in COVID-19: Pathogenesis and overview of anti-inflammatory agents used in treatment"},{"title3":"NIH COVID-19 Treatment Guidelines"},{"title3":"Increased Serum Levels of Soluble TNF-alpha Receptor Is Associated With ICU Mortality in COVID-19 Patients"},{"title3":"Levels of soluble CD14 and Tumor Necrosis Factor receptors 1 and 2 may be predictive of death in severe coronavirus disease 2019 (COVID-19)"},{"title3":"Association of TNF-alpha G-308 a promoter polymorphism with the course and outcome of COVID-19 patients"},{"title3":"Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity"},{"title3":"TNF promoter polymorphisms are associated with genetic susceptibility in COPD secondary to tobacco smoking and biomass burning"},{"title3":"Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals"},{"title3":"Genetic mechanisms of critical illness in COVID-19"},{"title3":"FLIP(L): The pseudo-caspase"},{"title3":"Transition from TNF-induced inflammation to death signaling"},{"title3":"HMGB1 as a Potential Biomarker and Therapeutic Target for Severe COVID-19"},{"title3":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes"},{"title3":"Unique immunological profile in patients with COVID-19"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"The critical role of Notch ligand delta-like 1 in the pathogenesis of influenza A virus (H1N1) infection"},{"title3":"Anti-TNF-alpha agents modulate SARS-CoV-2 receptors and increase the risk of infection through Notch-1 signaling"},{"title3":"ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19"},{"title3":"Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD"},{"title3":"Shedding of Tumor Necrosis Factor Receptor 1 induced by protein A decreases Tumor Necrosis Factor alpha availability and inflammation during systemic Staphylococcus aureus infection"},{"title3":"Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-CoV infection: A case-control study"},{"title3":"Validation of a composed COVID-19 chest radiography score: The CARE Project"},{"title3":"Frequency and distribution of chest radiographic findings in patients positive for COVID-19"},{"title3":"COVID-19 Clinical Management. Living Guidance 25 January 2021"},{"title3":"Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment"},{"title3":"COVID-19: Anti-TNF drug adalimumab to be trialled for patients in the community"}]},{"title2":"Tumor Necrosis Factor-alpha (TNF-alpha)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population - A case control study in a detailed perspective","References":[{"title3":"Impact of the - 308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease"},{"title3":"Tumor necrosis factor-alpha in malignant disease"},{"title3":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey"},{"title3":"Dietary fat intake and risk of pancreatic cancer in the prostate, lung, colorectal and ovarian cancer screening trial"},{"title3":"TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry"},{"title3":"Tumor necrosis factor or tumor promoting factor?"},{"title3":"Tumour necrosis factor and cancer"},{"title3":"TNF, apoptosis and autoimmunity: a common thread?"},{"title3":"Cytokine gene polymorphism in human disease: on-line databases"},{"title3":"How to track and assess genotyping errors in population genetics studies"},{"title3":"TNF microsatellite alleles in Brazilian Chagasic patients"},{"title3":"TNF-alpha-308G &gt; A polymorphism and colorectal cancer risk: a meta-analysis"},{"title3":"Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid"},{"title3":"Association of - 308 TNF-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma"},{"title3":"Inflammation and cancer"},{"title3":"Genetic polymorphism at position-308 in the promoter region of the tumor necrosis factor (TNF): implications of its allelic distribution on susceptibility or resistance to diseases in the Chilean population"},{"title3":"Cytokines in cancer pathogenesis and cancer therapy"},{"title3":"TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma"},{"title3":"Tumor necrosis factor-alpha gene - 308G &gt; A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population"},{"title3":"Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer"},{"title3":"Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation"},{"title3":"Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis"},{"title3":"Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China"},{"title3":"Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians"},{"title3":"Influence of TNFalpha gene polymorphisms on TNFalpha production and disease"},{"title3":"A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-cell lymphoma"},{"title3":"Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the - 308 tumor necrosis factor-alpha promoter gene"},{"title3":"Functional promoter -308G &gt; A variant in tumor necrosis factor alpha gene is associated with risk and progression of gastric cancer in a Chinese population"},{"title3":"The tumor necrosis factor-alpha-308 and -238 polymorphisms and risk of hepatocellular carcinoma for Asian populations: a meta-analysis"},{"title3":"Tumour necrosis factor mediates E-selectin production and leukocyte accumulation in myocardial ischaemia-reperfusion injury"},{"title3":"Global cancer statistics"},{"title3":"Association between the tumor necrosis factor alpha gene -308G &gt; A polymorphism and the risk of breast cancer: a meta-analysis"},{"title3":"A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD"},{"title3":"TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia"},{"title3":"The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription"},{"title3":"Effects of stimulus and cell type on the expression of the - 308 tumour necrosis factor promoter polymorphism"},{"title3":"Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer"},{"title3":"Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma"},{"title3":"Association between polymorphism of the tumor necrosis factor alpha-308 gene promoter and colon cancer in the Chinese population"},{"title3":"Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans"},{"title3":"Meta-analysis of association of tumor necrosis factor alpha-308 gene promoter polymorphism with gastric cancer"},{"title3":"Association between tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis"},{"title3":"Cancer-related inflammation"},{"title3":"Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation"},{"title3":"Genetic variation in the east Midlands"},{"title3":"Tumor necrosis factor-a polymorphisms and colorectal cancer risk: a meta-analysis"},{"title3":"Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis"},{"title3":"Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma"},{"title3":"Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer"},{"title3":"Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data"},{"title3":"Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients"},{"title3":"Functional polymorphisms in the promoterregions of matrix metalloproteinase-2, -3, -7, -9 and tnf-alpha genes, and the risk of colorectal neoplasm in Japanese"},{"title3":"Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan Public Health Center-based prospective study"},{"title3":"Association of TNF-alpha-308 and -238 polymorphisms with risk of cervical cancer: a meta-analysis"},{"title3":"Analysis of TNFB and TNFA NcoI RFLP in colorectal cancer"},{"title3":"Differential effects of aspirin before and after diagnosis of colorectal cancer"},{"title3":"Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer"},{"title3":"Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk"},{"title3":"Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6"},{"title3":"Macrophage diversity enhances tumor progression and metastasis"},{"title3":"Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide"},{"title3":"Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir"},{"title3":"Colorectal cancer: molecular mutations and polymorphisms"},{"title3":"Frequent genotype changes at - 308 of the human tumor necrosis factor-alpha promoter region in human uterine endometrial cancer"},{"title3":"Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer"},{"title3":"Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer"},{"title3":"Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1"},{"title3":"Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology"},{"title3":"Genomic structure, induction, and production of TNF-alpha"},{"title3":"Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha"},{"title3":"Role of tumor necrosis factor-alpha in disease states and inflammation"},{"title3":"Tumour necrosis factor alpha: a potential target for the therapy of solid tumours"},{"title3":"Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer"},{"title3":"Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer"},{"title3":"Global cancer incidence and mortality rates and trends-an update"},{"title3":"The role of anti-inflammatory drugs in colorectal cancer"},{"title3":"Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome"},{"title3":"Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk"},{"title3":"Tumour necrosis factor alpha-308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis"},{"title3":"The - 308G/A polymorphism of the tumor necrosis factor-alpha gene is associated with the risk of upper aerodigestive tract cancer: a meta-analysis"},{"title3":"Cancer trends in Kashmir; common types, site incidence and demographic profiles: National Cancer Registry 2000-2012"},{"title3":"Tumour necrosis factor in infectious disease"},{"title3":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product"},{"title3":"Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases"},{"title3":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation"},{"title3":"Infection, inflammation and colon carcinogenesis"},{"title3":"Association between TNF-alpha gene 308G &gt; A polymorphism and lung cancer risk: a meta-analysis"},{"title3":"The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis"},{"title3":"TNF-alpha polymorphisms and breast cancer"},{"title3":"Association of polymorphisms in tumor necrosis factor alpha and beta genes with increased risk for oral cancer"},{"title3":"Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis"},{"title3":"Different role of tumor necrosis factor-alpha polymorphism in non-Hodgkin lymphomas among Caucasian and Asian populations: a meta-analysis"},{"title3":"A systemic assessment of the association between tumor necrosis factor alpha 308G/A polymorphism and risk of cervical cancer"},{"title3":"Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis"},{"title3":"Associations between tumor necrosis factor-alpha polymorphisms and risk of psoriasis: a meta-analysis"},{"title3":"Corrupt policemen: inflammatory cells promote tumor angiogenesis"}]},{"title2":"An inflammatory cytokine signature predicts COVID-19 severity and survival","References":[{"title3":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area"},{"title3":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward"},{"title3":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages"},{"title3":"Advancing scientific knowledge in times of pandemics"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19"},{"title3":"Viral and host factors related to the clinical outcome of COVID-19"},{"title3":"Middle East respiratory syndrome: emergence of a pathogenic human coronavirus"},{"title3":"Cytokine release syndrome in severe COVID-19"},{"title3":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"},{"title3":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases"},{"title3":"Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils"},{"title3":"Myeloma CAR-T CRS management with IL-1R antagonist anakinra"},{"title3":"SOHO State of the Art updates and next questions: T-cell-directed immune therapies for multiple myeloma: chimeric antigen receptor-modified T cells and bispecific T-cell-engaging agents"},{"title3":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease"},{"title3":"Dexamethasone in hospitalized patients with COVID-19 : preliminary report"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Coronavirus breakthrough: dexamethasone is first drug shown to save lives"},{"title3":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents"},{"title3":"A practical guide to understanding Kaplan-Meier curves"},{"title3":"A note on competing risks in survival data analysis"},{"title3":"Subdistribution hazard models for competing risks in discrete time"},{"title3":"External validation of a Cox prognostic model: principles and methods"}]},{"title2":"Distinct cytokine profiles associated with COVID-19 severity and mortality","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study"},{"title3":"Cytokine release syndrome in severe COVID-19"},{"title3":"The immunobiology of SARS*"},{"title3":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},{"title3":"Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, et al. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives [published online ahead of print December 8, 2020]. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi.2020.11.025."},{"title3":"Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection"},{"title3":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity"},{"title3":"Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity"},{"title3":"Toxic effects of interferon"},{"title3":"Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C"},{"title3":"Obesity, diabetes and COVID-19: an infectious disease spreading from the east collides with the consequences of an unhealthy western lifestyle"},{"title3":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19"},{"title3":"Type I IFN immunoprofiling in COVID-19 patients"},{"title3":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19"},{"title3":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19"},{"title3":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients"},{"title3":"Human inborn errors of immunity: an expanding universe"},{"title3":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study"},{"title3":"Efficacy of tocilizumab in patients hospitalized with Covid-19"},{"title3":"Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial"},{"title3":"An inflammatory cytokine signature predicts COVID-19 severity and survival"},{"title3":"Dexamethasone in hospitalized patients with Covid-19:preliminary report"},{"title3":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood"},{"title3":"Considering personalized interferon-beta therapy for COVID-19"},{"title3":"Genetic mechanisms of critical illness in Covid-19"},{"title3":"Kwon YJ, Toussie D, Finkelstein M, Cedillo MA, Maron SZ, Manna S, et al. Combining initial radiographs and clinical variables improves deep learning prognostication of patients with COVID-19 from the emergency department [published online ahead of print December 16, 2020]. Radiol Artif Intell. https://doi.org/10.1148/ryai.2020200098."}]},{"title2":"Different profiles of antibodies and cytokines were found between severe and moderate COVID-19 patients","References":[{"title3":"Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study"},{"title3":"Multi-Platform Omics Analysis Reveals Molecular Signature for COVID-19 Pathogenesis, Prognosis and Drug Target Discovery"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Neutralizing Antibodies in Patients With Severe Acute Respiratory Syndrome-Associated Coronavirus Infection"},{"title3":"Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection"},{"title3":"A Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans"},{"title3":"A Comparison of Four Serological Assays for Detecting Anti-SARS-CoV-2 Antibodies in Human Serum Samples From Different Populations"},{"title3":"Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019"},{"title3":"Anti-Spike, Anti-Nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals"},{"title3":"IgA Dominates the Early Neutralizing Antibody Response to SARS-CoV-2"},{"title3":"Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019"},{"title3":"The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients"},{"title3":"The Evolution of IgE-Mediated Type I Hypersensitivity and its Immunological Value"},{"title3":"A Pneumonia Outbreak Associated With a New Coronavirus of Probable Bat Origin"},{"title3":"Human Neutralizing Antibodies Elicited by SARS-CoV-2 Infection"},{"title3":"A Noncompeting Pair of Human Neutralizing Antibodies Block COVID-19 Virus Binding to Its Receptor ACE2"},{"title3":"A Human Neutralizing Antibody Targets the Receptor Binding Site of SARS-CoV-2"},{"title3":"Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite"},{"title3":"Potent Neutralizing Antibodies Against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells"},{"title3":"Robust Neutralizing Antibodies to SARS-CoV-2 Infection Persist for Months"},{"title3":"Kinetics of Viral Load and Antibody Response in Relation to COVID-19 Severity"},{"title3":"Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019"},{"title3":"Serum IgA, IgM, and IgG Responses in COVID-19"},{"title3":"Longitudinal Observation and Decline of Neutralizing Antibody Responses in the Three Months Following SARS-CoV-2 Infection in Humans"},{"title3":"Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients"},{"title3":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China"},{"title3":"Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19"},{"title3":"Purification and Some Characteristics of Human T-Cell Growth Factor From Phytohemagglutinin-Stimulated Lymphocyte-Conditioned Media"},{"title3":"Tolerance, Not Immunity, Crucially Depends on IL-2. Nature Reviews"},{"title3":"IL-4 Production by Group 2 Innate Lymphoid Cells Promotes Food Allergy by Blocking Regulatory T-Cell Function"},{"title3":"Paradoxical Roles of IL-4 in Tumor Immunity"},{"title3":"IL-4 Induces M2 Macrophages to Produce Sustained Analgesia via Opioids"},{"title3":"Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia"},{"title3":"Bacterial Lipopolysaccharide and Inflammatory Mediators Augment IL-6 Secretion by Human Endothelial Cells"},{"title3":"Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells"},{"title3":"Peripheral Immunophenotypes in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection"},{"title3":"Biology and Therapeutic Potential of Interleukin-10"},{"title3":"Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease"},{"title3":"The Regulation of IL-10 Production by Immune Cells"},{"title3":"CXCL10 Could Drive Longer Duration of Mechanical Ventilation During COVID-19 ARDS"},{"title3":"Transcriptomic Characteristics of Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells in COVID-19 Patients"},{"title3":"COVID-19 Severity Correlates With Airway Epithelium-Immune Cell Interactions Identified by Single-Cell Analysis"},{"title3":"Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes"},{"title3":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China"},{"title3":"Cytokine Release Syndrome in Severe COVID-19"},{"title3":"Immunopathological Characteristics of Coronavirus Disease 2019 Cases in Guangzhou, China"},{"title3":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)"},{"title3":"Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019"},{"title3":"An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival"},{"title3":"Structural Basis for Neutralization of SARS-CoV-2 and SARS-CoV by a Potent Therapeutic Antibody"},{"title3":"Serologic and Molecular Biologic Methods for SARS-Associated Coronavirus Infection, Taiwan"},{"title3":"Robust Neutralizing Antibodies to SARS-CoV-2 Infection Persist for Months"},{"title3":"Humoral Immune Response to SARS-CoV-2 in Iceland"},{"title3":"Clinical Characteristics and Risk Factors for Severity of COVID-19 Outside Wuhan: A Double-Center Retrospective Cohort Study of 213 Cases in Hunan, China"},{"title3":"Viral and Antibody Kinetics of COVID-19 Patients With Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study"},{"title3":"Clinical, Laboratory, and Temporal Predictors of Neutralizing Antibodies to SARS-CoV-2 Among COVID-19 Convalescent Plasma Donor Candidates"},{"title3":"Kinetics of SARS-CoV-2 Specific IgM and IgG Responses in COVID-19 Patients"},{"title3":"Molecular Architecture of the SARS-CoV-2 Virus"},{"title3":"A Perspective on Potential Antibody-Dependent Enhancement of SARS-CoV-2"},{"title3":"Early Humoral Response Correlates With Disease Severity and Outcomes in COVID-19 Patients"},{"title3":"Interaction Network of SARS-CoV-2 With Host Receptome Through Spike Protein"},{"title3":"The Receptor Binding Domain of the Viral Spike Protein is an Immunodominant and Highly Specific Target of Antibodies in SARS-CoV-2 Patients"},{"title3":"Potent and Persistent Antibody Response in COVID-19 Recovered Patients"},{"title3":"Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19"},{"title3":"Serum IgA, IgM, and IgG Responses in COVID-19"},{"title3":"Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems"},{"title3":"Immunomodulatory Properties of Human Serum Immunoglobulin A: Anti-Inflammatory and Pro-Inflammatory Activities in Human Monocytes and Peripheral Blood Mononuclear Cells"},{"title3":"The Unexplored Roles of Human Serum IgA"},{"title3":"Monomeric and Polymeric IgA Show a Similar Association With the Myeloid FcalphaRI/Cd89"},{"title3":"Distinct Features of SARS-CoV-2-Specific IgA Response in COVID-19 Patients"},{"title3":"A T Cell-Dependent Mechanism for the Induction of Human Mucosal Homing Immunoglobulin A-Secreting Plasmablasts"},{"title3":"The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation"},{"title3":"Role of IgG3 in Infectious Diseases"},{"title3":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China"},{"title3":"Clinical Characteristics of Novel Coronavirus Cases in Tertiary Hospitals in Hubei Province"},{"title3":"SARS-CoV-2-Specific T Cell Responses and Correlations With COVID-19 Patient Predisposition"},{"title3":"Clinical Characteristics of 182 Pediatric COVID-19 Patients With Different Severities and Allergic Status"},{"title3":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study"},{"title3":"Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis"},{"title3":"Cytokine Regulation in SARS Coronavirus Infection Compared to Other Respiratory Virus Infections"},{"title3":"Immune Environment Modulation in Pneumonia Patients Caused by Coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2"},{"title3":"Dynamics of Cytokines and Lymphocyte Subsets Associated With the Poor Prognosis of Severe COVID-19"},{"title3":"Longitudinal COVID-19 Profiling Associates IL-1RA and IL-10 With Disease Severity and RANTES With Mild Disease"},{"title3":"Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 are Disease Severity Predictors"}]},{"title2":"Cytokines and their relationship with the severity and prognosis of Coronavirus Disease 2019 (COVID-19): a retrospective cohort study","References":[{"title3":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence"},{"title3":"World Health organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)"},{"title3":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020"},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia"},{"title3":"Interleukin-6 as a potential biomarker of COVID-19 progression"},{"title3":"The potential role of IL-6 in monitoring severe case of coronavirus disease 2019"},{"title3":"COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients"},{"title3":"Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients"},{"title3":"Clinical and immunological features of severe and moderate coronavirus disease 2019"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Active replication of middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"The clinical usefulness of the measurement of cytokines"},{"title3":"Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Predictive value of IL-8 for sepsis and severe infections after burn injury: a clinical study"},{"title3":"Plasma cytokine levels predict mortality in patients with acute renal failure"},{"title3":"Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients"},{"title3":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies"},{"title3":"How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1"},{"title3":"Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies"},{"title3":"[Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures]"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology"},{"title3":"Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis"},{"title3":"Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: findings from the observational multicentre Italian CORIST study"},{"title3":"Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept"},{"title3":"COVID-19 in patients with rheumatological diseases treated with anti-TNF"}]},{"title2":"Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis","References":[]},{"title2":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis","References":[]},{"title2":"Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19","References":[{"title3":"COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal"},{"title3":"Features of Severe COVID-19: A Systematic Review and Meta-Analysis"},{"title3":"Predicting Clinical Outcome With Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients From the Spanish Registry SEMI-COVID-19"},{"title3":"Human Genetic Factors Associated With Susceptibility to SARS-CoV-2 Infection and COVID-19 Disease Severity"},{"title3":"COVID-19 One Year Into the Pandemic: From Genetics and Genomics to Therapy, Vaccination, and Policy"},{"title3":"Genomewide Association Study of Severe Covid-19 With Respiratory Failure"},{"title3":"Relationship Between the ABO Blood Group and the COVID-19 Susceptibility"},{"title3":"New Insights Into Genetic Susceptibility of COVID-19: An ACE2 and TMPRSS2 Polymorphism Analysis"},{"title3":"Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2"},{"title3":"APOE E4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort"},{"title3":"Breadth of Concomitant Immune Responses Prior to Patient Recovery: A Case Report of non-Severe COVID-19"},{"title3":"Inborn Errors of Type I IFN Immunity in Patients With Life-Threatening COVID-19"},{"title3":"Presence of Genetic Variants Among Young Men With Severe COVID-19"},{"title3":"Association of Toll-Like Receptor 7 Variants With Life-Threatening COVID-19 Disease in Males: Findings From a Nested Case-Control Study"},{"title3":"The Mutational Constraint Spectrum Quantified From Variation in 141,456 Humans"},{"title3":"Sex-Specific Association of X-Linked Toll-Like Receptor 7 (TLR7) With Male Systemic Lupus Erythematosus"},{"title3":"Human TLRs and IL-1Rs in Host Defense: Natural Insights From Evolutionary, Epidemiological, and Clinical Genetics"},{"title3":"Molecular Underpinnings of Severe Coronavirus Disease 2019"},{"title3":"Pan-Ancestry Exome-Wide Association Analyses of COVID-19 Outcomes in 586, 157 Individuals"},{"title3":"Rare Variants Increase the Risk of Severe COVID-19"},{"title3":"Considering How Biological Sex Impacts Immune Responses and COVID-19 Outcomes"},{"title3":"Vitamin D and Aging: Beyond Calcium and Bone Metabolism"},{"title3":"Age and Low Levels of Circulating Vitamin D are Associated With Impaired Innate Immune Function"},{"title3":"Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes"},{"title3":"IFN-alpha2a Therapy in Two Patients With Inborn Errors of TLR3 and IRF3 Infected With SARS-CoV-2"},{"title3":"Seasonal Human Coronavirus Antibodies are Boosted Upon SARS-CoV-2 Infection But Not Associated With Protection"}]},{"title2":"Frequencies of Apolipoprotein E polymorphism in Iraqi Kurdish population","References":[]}]}]}